BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schäfer N, Grässel S. Involvement of complement peptides C3a and C5a in osteoarthritis pathology. Peptides 2022. [DOI: 10.1016/j.peptides.2022.170815] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Schäfer N, Grässel S. Targeted therapy for osteoarthritis: progress and pitfalls. Nat Med 2022. [DOI: 10.1038/s41591-022-02057-x] [Reference Citation Analysis]
2 Clarke EJ, Johnson E, Caamaño Gutierrez E, Andersen C, Berg LC, Jenkins RE, Lindegaard C, Uvebrant K, Lundgren-åkerlund E, Turlo A, James V, Jacobsen S, Peffers MJ. Temporal extracellular vesicle protein changes following intraarticular treatment with integrin α10β1-selected mesenchymal stem cells in equine osteoarthritis. Front Vet Sci 2022;9. [DOI: 10.3389/fvets.2022.1057667] [Reference Citation Analysis]
3 Gabrili JJM, Villas-boas IM, Pidde G, Squaiella-baptistão CC, Woodruff TM, Tambourgi DV. Complement System Inhibition Modulates the Inflammation Induced by the Venom of Premolis semirufa, an Amazon Rainforest Moth Caterpillar. IJMS 2022;23:13333. [DOI: 10.3390/ijms232113333] [Reference Citation Analysis]
4 Clarke EJ, Johnson E, Gutierrez EC, Andersen C, Berg LC, Jenkins RE, Lindegaard C, Uvebrant K, Lundgren-åkerlund E, Turlo A, James V, Jacobsen S, Peffers MJ. Temporal Extracellular Vesicle Protein Changes following Intraarticular Treatment with Integrin α10β1-selected Mesenchymal Stem Cells in Equine Osteoarthritis.. [DOI: 10.1101/2022.09.30.510176] [Reference Citation Analysis]
5 Zheng R, Zhang Y, Zhang K, Yuan Y, Jia S, Liu J. The Complement System, Aging, and Aging-Related Diseases. IJMS 2022;23:8689. [DOI: 10.3390/ijms23158689] [Reference Citation Analysis]